Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Return on Sales (2016 - 2026)

Dexcom has reported Return on Sales over the past 17 years, most recently at 0.0% for Q1 2026.

  • Quarterly Return on Sales changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Sales was 0.0% for Q1 2026 at Dexcom, down from 0.0% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.0% in Q4 2023 and troughed at 0.0% in Q1 2023.
  • The 5-year median for Return on Sales is 0.0% (2024), against an average of 0.0%.
  • The largest YoY upside for Return on Sales was 0bps in 2022 against a maximum downside of 0bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then soared by 120bps to 0.0% in 2023, then plummeted by -45bps to 0.0% in 2024, then surged by 56bps to 0.0% in 2025, then fell by -21bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Return on Sales are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).